Expert Opinions on Managing Fertility and Pregnancy in Patients With Mucopolysaccharidosis

AUTOR(ES)

Stewart, Fiona

FONTE

J. inborn errors metab. screen.

DATA DE PUBLICAÇÃO

30/05/2019

RESUMO

Abstract The mucopolysaccharidosis (MPS) disorders are rare genetic diseases caused by deficiencies in lysosomal enzymes involved in the degradation of glycosaminoglycans, leading to pulmonary, cardiac and neurological dysfunctions, skeletal anomalies, impaired vision, and/or hearing and shortened life spans. Whereas in the past, few individuals with MPS reached adulthood, better diagnosis, multidisciplinary care, and new therapies have led to an increasing number of adult patients with MPS. Therefore, fertility and pregnancy questions in this patient population are becoming more important. Management of fertility issues and pregnancy in patients with MPS is challenging due to the lack of documented cases and a dearth in the literature on this topic. This review presents multidisciplinary expert opinions on managing fertility and pregnancy based on case studies and clinical experience presented at a meeting of MPS specialists held in Berlin, Germany, in April 2015. An overview of the existing literature on this subject is also included.

Documentos Relacionados

• Expert Recommendations on Monkeypox (MPX) in Pregnancy, Postpartum and Lactating Women
• Pregnancy outcome and fertility control in Aberdeen.
• Managing patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel - ABHH monoclonal gammopathies committe
• Managing palpitations and arrhythmias during pregnancy
• Unresolved questions in managing hypothyroidism during pregnancy